| 项目编号 |
PRJCA027074 |
| 项目标题 |
Multi center, randomized, double-blind, placebo-controlled clinical study on the effect of Henggliejin on aging markers in patients with type 2 diabetes |
| 涉及领域 |
Medical |
| 数据类型 |
Metabolomics sequencing
|
| 物种名称 |
Homo sapiens
|
| 描述信息 |
The purpose of this study was to evaluate the effect of Henggliejin on aging markers in patients with type 2 diabetes. Collect blood from subjects during the study. Using serum liquid chromatography-mass spectrometry technology to study changes in telomere length, serum metabolomics, body weight, body fat distribution, glucose and lipid metabolism, and pancreatic function in subjects after intervention. |
| 样品范围 |
Multiisolate |
| 发布日期 |
2025-05-26 |
| 出版信息 |
| PubMed ID |
文章标题 |
杂志名称 |
Doi |
发表年份 |
|
|
Single‐Cell Transcriptomic Analysis of the Immune Response to COVID‐19 and Tuberculosis Coinfection
|
Exploration
|
10.1002/EXP.20240022
|
2025
|
| 40912255
|
Effect of henagliflozin on aging biomarkers in patients with type 2 diabetes: A multicenter, randomized, double-blind, placebo-controlled study
|
Cell Reports Medicine
|
10.1016/j.xcrm.2025.102331
|
2025
|
|
|
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| No funding support
|
|
|
|
|
|
| 提交者 |
Jixiong
Xu (Jixiong.Xu@ncu.edu.cn)
|
| 提交单位 |
the First Affiliated Hospital of Nanchang University |
| 提交日期 |
2024-06-15 |
